STM Publishing Group Limited
Ethical Publishing Practice
We follow the ICMJE and COPE guidelines where applicable.
• All submission will be screened twice using Crosscheck to verify originality, once after submission and again prior to publication.
• Each paper should be original, with a similarity index of < 5% against any single paper and with a total similarity index of < 20% against all papers in the database.
• Similarity between new submitted manuscript and the papers previously published by the same research team or author should be no more than 50%.
• No retracted articles should be cited.
• For dishonorable events anonymously or non-anonymously reported, editors will contact the corresponding author of the paper with the issue and provide the results to the person who reported the event.
• For dishonorable events including redundant (duplicate) publication,
suspected plagiarism, and undisclosed conflicts of interest, the journal will abide by the regulations suggested by COPE guidelines (http://publicationethics.org/resources)
• Errors in the content of an article that impact meaning
• Errors that affect indexing (eg. author names)
• Abstracts containing errors or missing text
• Errors in CME articles or tests
• Unreliable findings (accident or misconduct)
• Findings previously published elsewhere without attribution
• Unethical research
Expression of Concern
• Investigation underway; Investigation results unreliable; Evidence of misconduct, but no investigation
• According to the ICMJE recommendations, the authors should follow all ethical principles for medical research involving humans and experimental animals. A statement with the name of ethics and the approval number where appropriate, must be included in the manuscript.
- Research involving human participants, human material, or human data
Ethics Approval: Research involving human participants, human material, or human data, must have been performed in accordance with the Declaration of Helsinki and must have been approved by an appropriate ethics committee. If a study has been granted an exemption from requiring ethics approval, this should also be detailed in the manuscript.
Consent to participate: For all research involving human participants, informed consent to participate in the study should be obtained from participants (or their parent or legal guardian in the case of children <16) and a statement should be provided in the manuscript. For manuscripts reporting studies involving vulnerable groups (for example, unconscious patients) where there is the potential for coercion (for example prisoners) or where consent may not have been fully informed, manuscripts will be considered at the editor’s discretion and may be referred to an internal editorial oversight group for further scrutiny. Consent must be obtained for all forms of personally identifiable data including biomedical, clinical, and biometric data. In the case of articles describing human transplantation studies, authors must include a statement declaring that no organs/tissues were obtained from prisoners and must also name the institution(s)/clinic(s)/department(s) via which organs/tissues were obtained. Documentary evidence of consent must be supplied if requested.
Clinical Trial Registration: Prospective and interventional clinical trials should be registered in advance at a clinical trial registry approved by the WHO Registry Network. The date of registration and registration number should be indicated in the submission. Purely observational studies do not require registration.
- Research involving animals
Experimental research on animals must comply with institutional, national, or international guidelines, and where available should have been approved by an appropriate ethics committee.
The process for handling cases regarding corrections, retractions, and editorial expression of concern:
The Journal publishes corrections, retractions, and expressions of concern as appropriate, and as quickly as possible.
To request a correction/retraction,please contact the editorial office directly.
1. All advertisements are subject to approval of the Publisher, or Editor. However, the Publisher or the Editor shall not unreasonably withhold such approval.
2. Advertising is separate from content. Advertisers and sponsors have no advance knowledge of our editorial content, nor do the editors shape content toaccommodate advertising. Publisher will not sell advertising for a specificproduct on the condition that it appear in the same location, and at the same time, as a specific article mentioning that product, unless clearly labeled asan exclusive sponsor. Advertisers do not influence any of our editorial decisions or advertising policies.
3. The appearance of advertising on our journal is neither a guarantee nor anendorsement by the publisher, society or editorial partner of the product,service, or company and claims made in such advertising.